
View from the Top
Nicolás Linares
Executive Director and General Manager
Ultragenyx Pharmaceutical
https://www.linkedin.com/in/nicolas-linares-mba-3a11755/?originalSubdomain=mx
The discussion regarding rare diseases should focus on outcomes and impact instead of cost, says Ultragenyx’s Nicolás Linares.